SCHEMBL3314052

SCHEMBL3314052

c1ccc(C2CCCc3cccnc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.46
ALOX15 P16050 1/20 0.46
ADRA2A P08913 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1B P35368 1/20 0.43
KCNH2 Q12809 2/20 0.41
OPRL1 P41146 1/20 0.41
CXCR4 P61073 8/20 0.41
CYP2D6 P10635 5/20 0.40
OPRM1 P35372 2/20 0.40
HTR1A P08908 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1698202 0.90 OPRL1 (0.46) ADRA1AKCNH2OPRL1TAAR1
SCHEMBL27616525 0.86 IGF1R (0.40) IGF1RALOX15ADRA2AADRA1AADRA1D
SCHEMBL7839214 0.82 KDM4E (0.44) CXCR4CYP2D6ALDH1A1
SCHEMBL27616527 0.78 ADRA2A (0.46) IGF1RALOX15ADRA2AADRA1AADRA1D
SCHEMBL13857919 0.77 HDAC1 (0.41) KCNH2OPRL1CXCR4CYP2D6HDAC1
SCHEMBL19010006 0.77 IGF1R (0.46) IGF1RALOX15ADRA2AADRA1AADRA1D
SCHEMBL7839211 0.76 CXCR4 (0.46) CXCR4CYP2D6
SCHEMBL23850650 0.74 HDAC1 (0.41) CXCR4CYP2D6HDAC1HDAC6
SCHEMBL12891529 0.74 CYP2D6 (0.43) CXCR4CYP2D6HDAC1HDAC6
SCHEMBL12993082 0.74 HDAC1 (0.41) CXCR4CYP2D6HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100105915-A1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS ANORMED INC. (CA) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105915-A1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS CXCR4, CCR5, CXCR3 IGF1R 2568/4885ALOX15 2246/4885ADRA2A 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.